During the past decade, Istituto Europeo di Oncologia Servizio Radioterapia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Istituto Europeo di Oncologia Servizio Radioterapia" are "Castration-Resistant Prostatic Neoplasms" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Istituto Europeo di Oncologia Servizio Radioterapia" in a lesser frequency.

Most popular intervention types in "Istituto Europeo di Oncologia Servizio Radioterapia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apalutamide 240 mg" (1 trials), "Cetrelimab 480 mg" (1 trials) and "JNJ-63723283" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Europeo di Oncologia Servizio Radioterapia" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Istituto Europeo di Oncologia Servizio Radioterapia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Istituto Europeo di Oncologia Servizio Radioterapia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Europeo di Oncologia Servizio Radioterapia, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".